Download and use
- All data (JSON)
- Upper limits and daily reference intakes (CSV)
- Drug–supplement interactions (CSV)
- Lab result bands (CSV)
- Licensed vitamin and mineral medicines in Türkiye: counts by ATC code (CSV)
- Licensed single-ingredient vitamin and mineral medicines in Türkiye: counts by form and strength (CSV)
- Version
- 1.2 · November 12, 2026
- Source check
- Sources were last checked on October 3, 2026.
- License
- Creative Commons Attribution 4.0 (CC BY 4.0). You may copy, share and adapt it if you give credit.
- Citation
- Doktorclub. Doktorclub Vitamin and Mineral Data Set, version 1.2 (2026-11-12). https://doktorclub.com/en/vitamin-mineral-rehberi/veri
- Scope
- Adults over 18. The lab bands do not cover pregnancy or breastfeeding.
- Translation
- Translated from the Turkish data set, which is the reference text. Numbers, units and sources are identical. The translation has not been separately reviewed by a physician.
This data is for general information; it does not diagnose and does not recommend a dose. The laboratory reference range on your report and your doctor’s interpretation always take priority. If you see an error, tell us.
Upper limits and daily reference intakes
The upper limit is the highest amount not expected to cause harm when taken every day over a long period; it is not a target. The EFSA value comes first; where EFSA gives no value, the US Institute of Medicine (IOM) value is used and the row says so.
| Nutrient | Upper limit (adults) | Applies to | Body, year | Daily reference intake | Note | Source |
|---|---|---|---|---|---|---|
| Vitamin D | 100 µg/day | total intake | EFSA, 2023 | 15 µg/day AI (adequate intake) · EFSA 2017 | The EFSA 2023 upper limit is also 100 µg/day for pregnant and breastfeeding women and for ages 11–17. For ages 1–10 it is 50 µg/day. | doi.org, efsa.europa.eu |
| Vitamin A (preformed retinol) | 3,000 µg RE/day | total intake (preformed vitamin A only: retinol and retinyl esters) | EFSA, 2024 | Men 750, women 650 µg RE/day PRI (population reference intake) · EFSA 2017 | The upper limit is the same for pregnant women, breastfeeding women and postmenopausal women. There is no upper limit for beta-carotene. People who smoke should avoid supplements containing beta-carotene. | doi.org, efsa.europa.eu |
| Vitamin E | 300 mg/day | total intake | EFSA, 2024 | Men 13, women 11 mg/day AI (adequate intake) · EFSA 2017 | In 2024 EFSA kept the value set in 2003. The upper limit does not apply to people taking medicines such as blood thinners or aspirin. They should consult a doctor. | doi.org, efsa.europa.eu |
| Vitamin K | Not set | 70 µg/day AI (adequate intake) · EFSA 2017 | EFSA and the US Institute of Medicine (IOM) have not set an upper limit because there is not enough data. No harm has been reported from food or supplements. For people taking warfarin, the main issue is not an upper limit but keeping vitamin K intake regular and consistent. | efsa.europa.eu, ods.od.nih.gov, efsa.europa.eu | ||
| Vitamin C (guide in Turkish) | 2,000 mg/day | total intake | IOM (US Institute of Medicine) | Men 110, women 95 mg/day PRI (population reference intake) · EFSA 2017 | EFSA has not set an upper limit; this value is the US IOM value. In people with hemochromatosis, high vitamin C intake can increase iron absorption. | ods.od.nih.gov, efsa.europa.eu |
| Vitamin B6 | 12 mg/day | total intake | EFSA, 2023 | Men 1.7, women 1.6 mg/day PRI (population reference intake) · EFSA 2017 | The EFSA 2023 upper limit also covers pregnant and breastfeeding women. The IOM value in the US is 100 mg/day; this tool uses the lower EFSA value. | doi.org, efsa.europa.eu |
| Vitamin B12 | Not set | 4 µg/day AI (adequate intake) · EFSA 2017 | EFSA found no identified adverse effect. The US IOM also set no upper limit because of low toxicity. Taking supplements can raise the B12 level in the blood. The doctor should be told before the test (NICE NG239). | efsa.europa.eu, ods.od.nih.gov, efsa.europa.eu | ||
| Folic acid (synthetic) | 1,000 µg/day | supplements and fortified foods only (folic acid + methylfolate salts) | EFSA, 2023 | 330 µg DFE/day PRI (population reference intake) · EFSA 2017 | The upper limit does not cover natural folate in foods. It is also 1,000 µg/day for pregnant and breastfeeding women. | doi.org, efsa.europa.eu |
| Biotin (B7) | Not set | 40 µg/day AI (adequate intake) · EFSA 2017 | EFSA and the US IOM have not set an upper limit because there is not enough data. High-dose biotin can make some blood tests misleading. Even a single 10 mg dose has affected thyroid tests within 24 hours. | efsa.europa.eu, ods.od.nih.gov, efsa.europa.eu | ||
| Niacin (B3): nicotinamide | 900 mg/day | nicotinamide in supplements and fortified foods only | SCF/EFSA, 2002 | 1.6 mg NE/MJ PRI (population reference intake) · EFSA 2017 | The upper limits do not apply to pregnancy and breastfeeding. They also do not cover treatment use under medical supervision. The nicotinic acid limit was set on the basis of flushing. | efsa.europa.eu, efsa.europa.eu |
| Niacin (B3): nicotinic acid | 10 mg/day | free nicotinic acid (supplements and fortified foods) | SCF/EFSA, 2002 | 1.6 mg NE/MJ PRI (population reference intake) · EFSA 2017 | The upper limit was set on the basis of flushing and does not apply to pregnancy and breastfeeding. It does not cover treatment use under medical supervision; do not take high-dose nicotinic acid without consulting your doctor. | efsa.europa.eu, efsa.europa.eu |
| Iron | 45 mg/day | total intake (elemental iron) | IOM (US Institute of Medicine) | Men 11, women 16 mg/day PRI (population reference intake) · EFSA 2017 | In 2024 EFSA was unable to set an upper limit for iron. Instead, it defined a "safe level of intake" of 40 mg/day for adults. The EFSA safe level is also 40 mg/day for pregnant and breastfeeding women. | ods.od.nih.gov, efsa.europa.eu |
| Zinc (guide in Turkish) | 25 mg/day | total intake | SCF/EFSA, 2002 | Men 9.4–16.3, women 7.5–12.7 mg/day PRI (population reference intake) · EFSA 2017 | It is also 25 mg/day for pregnant and breastfeeding women. The US IOM value is 40 mg/day; the tool uses the EFSA value. | efsa.europa.eu, efsa.europa.eu |
| Magnesium (from supplements) | 250 mg/day | easily soluble salts in supplements, water and fortified foods only | SCF/EFSA, 2001 | Men 350, women 300 mg/day AI (adequate intake) · EFSA 2017 | Natural magnesium in foods is not included in this limit. The US IOM limit for supplements is 350 mg/day; the tool uses the EFSA value. | efsa.europa.eu, efsa.europa.eu |
| Calcium (guide in Turkish) | 2,500 mg/day | total intake | EFSA, 2012 | 950 mg/day PRI (population reference intake) · EFSA 2017 | It is also 2,500 mg/day for pregnant and breastfeeding women. The US IOM value is 2,000 mg/day above age 51. | efsa.europa.eu, efsa.europa.eu |
| Iodine | 600 µg/day | total intake | SCF/EFSA, 2003 | 150 µg/day AI (adequate intake) · EFSA 2017 | It is also 600 µg/day for pregnant and breastfeeding women. It is 450 µg/day for ages 11–14 and 500 µg/day for ages 15–17. | efsa.europa.eu, efsa.europa.eu |
| Selenium | 255 µg/day | total intake | EFSA, 2023 | 70 µg/day AI (adequate intake) · EFSA 2017 | It is also 255 µg/day for pregnant and breastfeeding women. Eating Brazil nuts regularly can exceed the limit. | doi.org, efsa.europa.eu |
| Copper | 5 mg/day | total intake | SCF/EFSA, 2003 | Men 1.6, women 1.3 mg/day AI (adequate intake) · EFSA 2017 | In 2023 EFSA set an acceptable daily intake for copper of 0.07 mg per kg of body weight. No upper limit has been defined for pregnancy and breastfeeding. | efsa.europa.eu, efsa.europa.eu |
| Potassium | Not set | 3,500 mg/day AI (adequate intake) · EFSA 2017 | EFSA and the US National Academies have not set an upper limit for potassium. This does not mean that supplements are safe for everyone. In chronic kidney disease, or with some blood pressure medicines and diuretics (water pills), blood potassium can rise to dangerous levels. Consult a doctor before using supplements or potassium-containing salt substitutes. | efsa.europa.eu, ods.od.nih.gov, efsa.europa.eu | ||
| Omega-3 (EPA+DHA) (guide in Turkish) | Not set | 250 mg EPA+DHA/day AI (adequate intake) · EFSA 2010 | EFSA did not find enough data to set an upper limit for EPA, DHA and DPA. INR monitoring is recommended for people taking warfarin. In people at high risk of heart disease, the risk of atrial fibrillation was slightly increased at doses of 4 g/day. | doi.org, efsa.europa.eu |
Drug–supplement interactions
The list is not complete; it holds known, important interactions for which a source can be shown. Do not stop your medicines or change their dose on your own. To look up your own medicine, use the interaction checker.
| Supplement | Drug class | Severity | Effect | What to do | Source |
|---|---|---|---|---|---|
| Calcium (calcium carbonate) | Thyroid hormone levothyroxine | moderate | Calcium carbonate can reduce the absorption of levothyroxine. The prescribing information says the two should be taken at least 4 hours apart. | Plan the time gap with your pharmacist according to the medicine's package leaflet. Do not change your medicine on your own. | dailymed.nlm.nih.gov, ods.od.nih.gov |
| Iron (ferrous sulfate) | Thyroid hormone levothyroxine | moderate | Iron can bind to levothyroxine in the gut and reduce its absorption. In some people the effect of the medicine can drop noticeably. | Plan the time gap with your pharmacist according to the medicine's package leaflet. Tell your doctor that you have started taking iron. | dailymed.nlm.nih.gov, ods.od.nih.gov |
| Antacids containing magnesium or aluminum | Thyroid hormone levothyroxine | moderate | Antacids containing magnesium and aluminum hydroxide reduce stomach acid and can lower levothyroxine absorption. The prescribing information recommends monitoring people who use them together. | Plan with your pharmacist what time to take the antacid. If you use antacids often, tell your doctor; a TSH check may be needed. | dailymed.nlm.nih.gov |
| Vitamin K | Coumarin-type blood thinner warfarin | high | Vitamin K works against the effect of warfarin. A sudden change in intake can lower or raise your INR. | Do not cut out vitamin K from foods; eat a similar amount every day. Tell your doctor before starting or stopping a supplement that contains vitamin K. | dailymed.nlm.nih.gov, ods.od.nih.gov |
| Vitamin E (high-dose supplement) | Blood thinners and antiplatelet medicines warfarin; apixaban; rivaroxaban; acetylsalicylic acid; clopidogrel | moderate | High-dose vitamin E can increase the risk of bleeding. This risk is more marked if vitamin K intake is low. | If you take a vitamin E supplement, tell your doctor. If you take warfarin, do not skip your INR checks. | ods.od.nih.gov, doi.org |
| Omega-3 / fish oil | Coumarin-type blood thinner warfarin | low | Fish oil can prolong clotting time. In most studies, 3–6 g of fish oil a day did not noticeably affect INR. | Tell your doctor that you have started taking fish oil. Regular monitoring of your INR is recommended. | ods.od.nih.gov |
| Ginkgo, garlic supplements | Blood thinners and aspirin warfarin; apixaban; rivaroxaban; dabigatran; edoxaban; acetylsalicylic acid | moderate | Ginkgo and garlic can cause a tendency to bleed even on their own. Together with a blood thinner, the risk of bleeding may increase. | Consult your doctor before using these herbal products. Also mention them before surgery or a tooth extraction. | dailymed.nlm.nih.gov, nccih.nih.gov, nccih.nih.gov |
| St. John's wort | Coumarin-type blood thinner warfarin | high | St. John's wort can reduce the effect of warfarin. This can increase the risk of clots. | If you are taking or stopping St. John's wort, tell your doctor right away. INR should be checked more often. | nccih.nih.gov, dailymed.nlm.nih.gov |
| Calcium, iron, magnesium, zinc and multivitamins | Quinolone antibiotics ciprofloxacin; levofloxacin; moxifloxacin | moderate | These minerals bind to the antibiotic and reduce its absorption. The medicine may not work well enough against the infection. | The ciprofloxacin prescribing information says it should be taken 2 hours before or 6 hours after these products. For other quinolones, ask your pharmacist. | dailymed.nlm.nih.gov, ods.od.nih.gov, ods.od.nih.gov, ods.od.nih.gov |
| Calcium, iron, magnesium, zinc | Tetracycline-class antibiotics doxycycline; tetracycline; minocycline | moderate | Antacids containing calcium, magnesium or aluminum, and iron, impair tetracycline absorption. Zinc and tetracycline also reduce each other's absorption. | Plan the time gap with your pharmacist according to the medicine's package leaflet. You can talk to your doctor about pausing the supplement during the course of treatment. | dailymed.nlm.nih.gov, ods.od.nih.gov, ods.od.nih.gov |
| Calcium, magnesium, iron and antacids | Bisphosphonates (osteoporosis medicines) alendronate; risedronate; ibandronate | moderate | Calcium and other polyvalent minerals impair bisphosphonate absorption. The medicine is taken in the morning on an empty stomach, with water only. | Plan with your pharmacist what time to take your calcium supplement after the medicine. For magnesium, a gap of at least 2 hours is recommended. | dailymed.nlm.nih.gov, ods.od.nih.gov |
| Vitamin B12 (risk of deficiency) | Metformin metformin | moderate | Long-term metformin use can lower B12 absorption and blood levels. This can lead to anemia or nerve problems. | Do not stop metformin. Talk to your doctor about having your B12 level measured from time to time; ADA 2026 recommends considering this. | pmc.ncbi.nlm.nih.gov, dailymed.nlm.nih.gov, nice.org.uk |
| Vitamin B12 (risk of deficiency) | Proton pump inhibitors and H2 blockers omeprazole; lansoprazole; pantoprazole; esomeprazole; famotidine | moderate | Medicines that reduce stomach acid can reduce absorption of the B12 in foods. With long-term use, B12 deficiency can develop. | Do not stop your medicine on your own. If you have been taking it for a long time, talk to your doctor about a B12 test. | ods.od.nih.gov, nice.org.uk |
| Magnesium (risk of low levels) | Proton pump inhibitors omeprazole; lansoprazole; pantoprazole; esomeprazole; rabeprazole | moderate | Using a PPI for more than a year can lead to low magnesium in the blood. The FDA recommends measurement at the start and periodically. | If you have complaints such as muscle cramps or palpitations, tell your doctor. You can ask about a magnesium test. | ods.od.nih.gov |
| Iron | Proton pump inhibitors omeprazole; lansoprazole; pantoprazole; esomeprazole | low | When stomach acid is reduced, absorption of non-heme iron (the iron in plant foods and iron supplements) can fall. In people with iron deficiency, the response to iron treatment may be weaker than expected. | If you are on iron treatment and also take a PPI, tell your doctor. | ods.od.nih.gov |
| Iron (including the iron in multivitamins) | Parkinson's disease medicines levodopa; carbidopa | moderate | Iron salts can bind to levodopa and reduce its absorption. The effect of the medicine may be reduced. | Plan the time gap with your pharmacist according to the medicine's package leaflet. Tell your neurologist when you start iron. | dailymed.nlm.nih.gov, ods.od.nih.gov |
| Potassium supplements and potassium-containing salt substitutes | ACE inhibitors and ARBs (blood pressure medicines) lisinopril; enalapril; ramipril; perindopril; losartan; valsartan; candesartan; irbesartan | high | These medicines reduce the amount of potassium passed in the urine. Extra potassium can lead to a dangerous rise in the blood. | Consult your doctor before using a potassium supplement or potassium salt. | ods.od.nih.gov, dailymed.nlm.nih.gov |
| Potassium supplements and potassium-containing salt substitutes | Potassium-sparing diuretics (water pills) spironolactone; eplerenone; amiloride; triamterene | high | Potassium supplements with these medicines can lead to severe high potassium. The risk is higher if kidney function is impaired. | Consult your doctor before using a potassium supplement or a potassium-containing salt substitute. | dailymed.nlm.nih.gov, ods.od.nih.gov |
| Red yeast rice (monacolin K) | Statins (cholesterol medicines) atorvastatin; rosuvastatin; simvastatin; pravastatin; lovastatin | moderate | Monacolin K is structurally identical to lovastatin. Taken with a statin, muscle, liver and kidney side effects and drug interactions may increase. | If you take a statin, consult your doctor before adding this product. | nccih.nih.gov |
| St. John's wort | Hormonal birth control pills ethinyl estradiol; levonorgestrel; desogestrel; drospirenone | high | St. John's wort can weaken the effect of birth control pills. There may be a risk of unintended pregnancy. | If you take St. John's wort, tell your doctor or pharmacist. | nccih.nih.gov |
| St. John's wort | Antidepressants and medicines that act on serotonin sertraline; escitalopram; fluoxetine; paroxetine; amitriptyline; bupropion | high | The effect of some antidepressants may be reduced. With medicines that act on serotonin, serious serotonin side effects can develop. | If you take an antidepressant, consult your doctor before adding St. John's wort. | nccih.nih.gov |
| St. John's wort | Organ transplant medicines cyclosporine; tacrolimus | high | St. John's wort can reduce the effect of cyclosporine. This can pave the way for rejection of the transplanted organ. | If you take a transplant medicine, do not start any herbal product without consulting your doctor. | nccih.nih.gov |
| St. John's wort | Heart medicines digoxin; ivabradine | moderate | St. John's wort can reduce the effect of some heart medicines such as digoxin and ivabradine. | If you take a heart medicine, consult your doctor before using St. John's wort. | nccih.nih.gov |
| St. John's wort | Newer blood thinners apixaban; rivaroxaban | high | St. John's wort lowers the blood level of these medicines. The medicine may not protect well enough against clots. The prescribing information says they should not be used together. | If you take St. John's wort or want to stop it, tell the doctor who prescribed your medicine right away. Do not stop your blood thinner on your own. | dailymed.nlm.nih.gov, dailymed.nlm.nih.gov |
| St. John's wort | Some epilepsy medicines phenytoin; carbamazepine | moderate | St. John's wort can weaken the effect of some seizure medicines such as phenytoin and carbamazepine. This can impair seizure control. | If you take an epilepsy medicine, consult your neurologist before adding St. John's wort. | nccih.nih.gov |
| Biotin (high dose, including hair and nail products) | Laboratory tests: thyroid and some hormone tests | moderate | Biotin can cause falsely high or falsely low results in tests that use the biotin-streptavidin method. In thyroid tests it can lead to a wrong diagnosis. | Before giving blood, tell the laboratory and your doctor that you take biotin. Ask them how long you should stop it for. | doi.org, ods.od.nih.gov |
| Biotin (high dose) | Laboratory tests: troponin (heart attack test) | high | Biotin can cause a falsely low troponin result. A heart attack could be missed. | If you seek care for chest pain, be sure to say that you take biotin. | fda.gov, ods.od.nih.gov |
| Vitamin D and calcium supplements | Thiazide-type diuretics (water pills) hydrochlorothiazide; chlorthalidone; indapamide | moderate | Thiazides reduce the amount of calcium passed in the urine and can raise blood calcium. Monitoring is needed when they are taken with a vitamin D supplement. | If you take vitamin D or calcium, tell your doctor. You can ask about a calcium test. | ods.od.nih.gov, dailymed.nlm.nih.gov |
| Iodine, kelp and seaweed supplements | Antithyroid medicines methimazole; propylthiouracil | moderate | High-dose iodine together with an antithyroid medicine can lead to the thyroid gland being suppressed too much. The iodine content of kelp products varies widely. | If you have thyroid disease, do not use products containing iodine or seaweed without consulting your doctor. | ods.od.nih.gov |
| Vitamin A (retinol) | Oral retinoid medicines isotretinoin; acitretin | high | Retinoid medicines are similar to vitamin A. Taking a vitamin A supplement at the same time can increase the risk of toxicity. | While taking a retinoid, do not take supplements or multivitamins containing vitamin A without asking your doctor. | ods.od.nih.gov |
| Folic acid | Methotrexate methotrexate | moderate | Folic acid interacts with methotrexate. In cancer treatment it can alter the effect; with low-dose use it can reduce side effects. | Take folic acid only as your doctor recommends. Do not start or stop it on your own. | ods.od.nih.gov |
| Folic acid | Some epilepsy medicines phenytoin; carbamazepine; valproic acid | moderate | These medicines can lower folate in the blood. Folic acid supplements, in turn, can reduce the blood level of some medicines. | Consult your neurologist before taking folic acid. If you are planning a pregnancy, be sure to discuss that too. | ods.od.nih.gov |
| Calcium supplement | Lithium lithium | moderate | Long-term lithium can raise blood calcium. A calcium supplement can increase this risk. | If you take lithium, consult your doctor before taking a calcium supplement. | ods.od.nih.gov |
| Niacin (nicotinic acid, high dose) | Diabetes medicines metformin; insulin; gliclazide | moderate | High-dose nicotinic acid can raise blood sugar. The diabetes medicine may need to be adjusted. | If you have diabetes, consult your doctor before taking a niacin supplement. | ods.od.nih.gov |
| Melatonin (a TİTCK-licensed medicine in Türkiye) | Blood thinners (warfarin and newer blood thinners) warfarin; apixaban; rivaroxaban | moderate | According to the patient information leaflet of the licensed melatonin tablet in Türkiye, melatonin can increase the effect of warfarin and newer blood thinners and raise the risk of bleeding. NCCIH also recommends medical supervision for these people. In Türkiye, melatonin has not been allowed to be sold as a food supplement since June 9, 2025; it is available only in pharmacies as a medicine licensed by TİTCK (Turkish Medicines and Medical Devices Agency). | If you take a blood thinner, do not start melatonin without consulting your doctor. If a nosebleed or bleeding gums will not stop, or if you have black stools, go to the emergency department the same day. | titck.gov.tr, nccih.nih.gov, antalyaeo.org.tr |
| Melatonin (a TİTCK-licensed medicine in Türkiye) | Epilepsy medicines carbamazepine | moderate | According to the patient information leaflet of the licensed melatonin tablet, melatonin can increase seizure frequency in people with epilepsy. The leaflet says it should be used with caution together with carbamazepine. In Türkiye, melatonin has not been allowed to be sold as a food supplement since June 9, 2025; it is available only in pharmacies as a medicine licensed by TİTCK (Turkish Medicines and Medical Devices Agency). | Consult your neurologist before taking melatonin. | titck.gov.tr, nccih.nih.gov, antalyaeo.org.tr |
Lab result bands: vitamin D, B12, ferritin
The bands are guideline thresholds, not a laboratory reference range. A single value does not make a diagnosis on its own. For your own result, use the result interpreter.
| Test | Group | Range | Label | Explanation | Source |
|---|---|---|---|---|---|
| 25(OH) vitamin D | Adults | ≥ 0 and ≤ 12 ng/mL | Markedly low | According to TEMD 2025 (Society of Endocrinology and Metabolism of Türkiye), 12 ng/mL or below is the level at which the risk of osteomalacia (softening of the bones) increases. | file.temd.org.tr |
| 25(OH) vitamin D | Adults | > 12 and < 20 ng/mL | Low (insufficiency level) | TEMD 2025 defines a level below 20 ng/mL as insufficiency (deficiency) and recommends treatment at this level. Your doctor decides on the diagnosis and treatment. | file.temd.org.tr |
| 25(OH) vitamin D | Adults | ≥ 20 and ≤ 50 ng/mL | Adequate and safe range | According to TEMD 2025, 20–50 ng/mL is the adequate and safe range. | file.temd.org.tr |
| 25(OH) vitamin D | Adults | > 50 and ≤ 100 ng/mL | Above the adequate range | The value is above the 20–50 range that TEMD considers safe. NIH ODS links levels above 50 ng/mL with possible adverse effects. | file.temd.org.tr, ods.od.nih.gov |
| 25(OH) vitamin D | Adults | > 100 and ≤ 150 ng/mL | Increased risk of toxicity | According to TEMD 2025, the risk of vitamin D toxicity increases above 100 ng/mL. | file.temd.org.tr |
| 25(OH) vitamin D | Adults | > 150 ng/mL | Very high | According to TEMD 2025, symptoms of high calcium appear above 150 ng/mL. | file.temd.org.tr |
| Vitamin B12 (total B12) | Adults | ≥ 0 and < 180 ng/L | Low | According to NICE NG239, a level below 180 ng/L is consistent with B12 deficiency. Your doctor makes the diagnosis together with your symptoms. | nice.org.uk |
| Vitamin B12 (total B12) | Adults | ≥ 180 and ≤ 350 ng/L | Indeterminate range | According to NICE, 180–350 ng/L is indeterminate; there may or may not be a deficiency. | nice.org.uk |
| Vitamin B12 (total B12) | Adults | > 350 ng/L | Deficiency unlikely | According to NICE, a level above 350 ng/L makes B12 deficiency unlikely. | nice.org.uk |
| Ferritin | Men | ≥ 0 and < 15 µg/L | Low | According to WHO 2020, a level below 15 µg/L in a healthy adult indicates iron deficiency. Your doctor assesses the result and its cause. | ncbi.nlm.nih.gov |
| Ferritin | Men | ≥ 15 and < 70 µg/L | May count as low if there is inflammation | When infection or inflammation is present, WHO regards a level below 70 µg/L as a sign of iron deficiency. | ncbi.nlm.nih.gov |
| Ferritin | Men | ≥ 70 and ≤ 200 µg/L | Usual according to WHO thresholds | According to WHO thresholds, there is no sign of deficiency or of iron overload. | ncbi.nlm.nih.gov |
| Ferritin | Men | > 200 and ≤ 500 µg/L | High | According to WHO, in a healthy adult this level may indicate a risk of iron overload. Inflammation also raises ferritin. | ncbi.nlm.nih.gov, doi.org |
| Ferritin | Men | > 500 µg/L | Very high | According to WHO, a level above 500 µg/L may indicate a risk of iron overload even in adults who have an illness. | ncbi.nlm.nih.gov |
| Ferritin | Women (menstruating) | ≥ 0 and < 15 µg/L | Low | According to WHO 2020, a level below 15 µg/L in a healthy adult indicates iron deficiency. Your doctor assesses the result and its cause. | ncbi.nlm.nih.gov |
| Ferritin | Women (menstruating) | ≥ 15 and < 70 µg/L | May count as low if there is inflammation | When infection or inflammation is present, WHO regards a level below 70 µg/L as a sign of iron deficiency. | ncbi.nlm.nih.gov |
| Ferritin | Women (menstruating) | ≥ 70 and ≤ 150 µg/L | Usual according to WHO thresholds | According to WHO thresholds, there is no sign of deficiency or of iron overload. | ncbi.nlm.nih.gov |
| Ferritin | Women (menstruating) | > 150 and ≤ 500 µg/L | High | According to WHO, in a healthy adult this level may indicate a risk of iron overload. Inflammation also raises ferritin. | ncbi.nlm.nih.gov, doi.org |
| Ferritin | Women (menstruating) | > 500 µg/L | Very high | According to WHO, a level above 500 µg/L may indicate a risk of iron overload even in adults who have an illness. | ncbi.nlm.nih.gov |
| Ferritin | Women (not menstruating) | ≥ 0 and < 15 µg/L | Low | According to WHO 2020, a level below 15 µg/L in a healthy adult indicates iron deficiency. Your doctor assesses the result and its cause. | ncbi.nlm.nih.gov |
| Ferritin | Women (not menstruating) | ≥ 15 and < 70 µg/L | May count as low if there is inflammation | When infection or inflammation is present, WHO regards a level below 70 µg/L as a sign of iron deficiency. | ncbi.nlm.nih.gov |
| Ferritin | Women (not menstruating) | ≥ 70 and ≤ 200 µg/L | Usual according to WHO thresholds | According to WHO thresholds, there is no sign of deficiency or of iron overload. | ncbi.nlm.nih.gov |
| Ferritin | Women (not menstruating) | > 200 and ≤ 500 µg/L | High | According to WHO, in a healthy adult this level may indicate a risk of iron overload. Inflammation also raises ferritin. | ncbi.nlm.nih.gov, doi.org |
| Ferritin | Women (not menstruating) | > 500 µg/L | Very high | According to WHO, a level above 500 µg/L may indicate a risk of iron overload even in adults who have an illness. | ncbi.nlm.nih.gov |
Licensed vitamin and mineral medicines in Türkiye
According to the Doktorclub drug guide (İlaç Rehberi) data of October 28, 2026, there are 240 products on the market: Vitamins (A11) 114, Mineral supplements (A12) 60, Iron preparations (B03A) 50, Vitamin B12 and folic acid (B03B) 16. Each barcode (pack) is counted separately. Food supplements are not licensed as medicines and are not in these counts.
The “On SGK list” column shows that the product is on the reimbursement list (Annex 4/A) of the Social Security Institution (SGK), the public payer; reimbursement conditions depend on the product and the prescription.
| Group | ATC code | ATC name | Products | On SGK list | Forms | Source |
|---|---|---|---|---|---|---|
| Vitamins (A11) | A11AA03 | multivitamins and other minerals, incl. combinations | 1 | 1 | film-coated tablet | İlaç Rehberi (in Turkish) |
| Vitamins (A11) | A11BA | Multivitamins, plain | 5 | 5 | syrup | İlaç Rehberi (in Turkish) |
| Vitamins (A11) | A11CA01 | retinol (vit a) | 1 | 1 | capsule | İlaç Rehberi (in Turkish) |
| Vitamins (A11) | A11CC04 | calcitriol | 12 | 12 | solution for injection; capsule | İlaç Rehberi (in Turkish) |
| Vitamins (A11) | A11CC05 | colecalciferol | 53 | 52 | capsule; drops; film-coated tablet; oral solution; ampoule; solution | İlaç Rehberi (in Turkish) |
| Vitamins (A11) | A11DA02 | sulbutiamine | 1 | 0 | coated tablet (dragée) | İlaç Rehberi (in Turkish) |
| Vitamins (A11) | A11DA03 | benfotiamine | 2 | 0 | film-coated tablet | İlaç Rehberi (in Turkish) |
| Vitamins (A11) | A11DB | Various alimentary tract and metabolism products | 12 | 12 | film-coated tablet; solution for injection; enteric-coated tablet; tablet | İlaç Rehberi (in Turkish) |
| Vitamins (A11) | A11EA | Vitamin B-complex, plain | 3 | 3 | solution for injection | İlaç Rehberi (in Turkish) |
| Vitamins (A11) | A11EB | Vitamin B-complex with vitamin C | 2 | 0 | film-coated tablet | İlaç Rehberi (in Turkish) |
| Vitamins (A11) | A11EX | Various alimentary tract and metabolism products | 1 | 1 | enteric-coated tablet | İlaç Rehberi (in Turkish) |
| Vitamins (A11) | A11GA01 | ascorbic acid (vit c) | 4 | 3 | solution for injection; effervescent tablet | İlaç Rehberi (in Turkish) |
| Vitamins (A11) | A11HA02 | pyridoxine (vit B6) | 1 | 1 | tablet | İlaç Rehberi (in Turkish) |
| Vitamins (A11) | A11HA03 | tocopherol (vit E) | 7 | 4 | capsule; solution for injection | İlaç Rehberi (in Turkish) |
| Vitamins (A11) | A11HA05 | biotin | 3 | 3 | tablet | İlaç Rehberi (in Turkish) |
| Vitamins (A11) | A11HA30 | dexpanthenol | 3 | 2 | solution for injection | İlaç Rehberi (in Turkish) |
| Vitamins (A11) | A11JA | Combinations of vitamins | 2 | 2 | drops | İlaç Rehberi (in Turkish) |
| Vitamins (A11) | A11JC | Vitamins, other combinations | 1 | 0 | capsule | İlaç Rehberi (in Turkish) |
| Mineral supplements (A12) | A12AA04 | calcium carbonate | 2 | 2 | effervescent tablet; film-coated tablet | İlaç Rehberi (in Turkish) |
| Mineral supplements (A12) | A12AA20 | combinations of electrolytes | 3 | 3 | solution for injection | İlaç Rehberi (in Turkish) |
| Mineral supplements (A12) | A12AX | Calcium, combinations with vitamin D and/or other drugs | 15 | 15 | effervescent tablet; film-coated tablet; granules; sachet; orodispersible tablet; chewable tablet | İlaç Rehberi (in Turkish) |
| Mineral supplements (A12) | A12BA02 | potassium citrate | 1 | 1 | prolonged-release tablet | İlaç Rehberi (in Turkish) |
| Mineral supplements (A12) | A12BA30 | potassium (different salts in combination) | 3 | 3 | effervescent tablet | İlaç Rehberi (in Turkish) |
| Mineral supplements (A12) | A12C | OTHER MINERAL SUPPLEMENTS | 2 | 2 | film-coated tablet | İlaç Rehberi (in Turkish) |
| Mineral supplements (A12) | A12CB01 | zinc sulfate | 22 | 22 | syrup; capsule | İlaç Rehberi (in Turkish) |
| Mineral supplements (A12) | A12CC02 | magnesium sulfate | 6 | 6 | solution for injection; solution for infusion; ampoule | İlaç Rehberi (in Turkish) |
| Mineral supplements (A12) | A12CC10 | magnesium oxide | 5 | 5 | effervescent tablet; tablet; film-coated tablet | İlaç Rehberi (in Turkish) |
| Mineral supplements (A12) | A12CC30 | magnesium (different salts in combination) | 1 | 1 | sachet | İlaç Rehberi (in Turkish) |
| Iron preparations (B03A) | B03AA01 | ferrous glycine sulfate | 2 | 2 | capsule | İlaç Rehberi (in Turkish) |
| Iron preparations (B03A) | B03AA02 | ferrous fumarate | 1 | 1 | capsule | İlaç Rehberi (in Turkish) |
| Iron preparations (B03A) | B03AA07 | ferrous sulfate | 2 | 2 | coated tablet (dragée); prolonged-release tablet | İlaç Rehberi (in Turkish) |
| Iron preparations (B03A) | B03AB05 | ferric oxide polymaltose complexes | 14 | 13 | oral solution; syrup; drops; sachet | İlaç Rehberi (in Turkish) |
| Iron preparations (B03A) | B03AB09 | ferric proteinsuccinylate | 1 | 1 | oral solution | İlaç Rehberi (in Turkish) |
| Iron preparations (B03A) | B03AC | Iron, parenteral preparations | 15 | 14 | solution for injection; ampoule; solution for infusion | İlaç Rehberi (in Turkish) |
| Iron preparations (B03A) | B03AD | Iron in combination with folic acid | 2 | 2 | oral solution | İlaç Rehberi (in Turkish) |
| Iron preparations (B03A) | B03AD03 | ferrous sulfate | 2 | 2 | coated tablet (dragée); prolonged-release tablet | İlaç Rehberi (in Turkish) |
| Iron preparations (B03A) | B03AD04 | ferric oxide polymaltose complexes | 4 | 4 | film-coated tablet; tablet | İlaç Rehberi (in Turkish) |
| Iron preparations (B03A) | B03AE01 | iron, vitamin b12 and folic acid | 1 | 1 | capsule | İlaç Rehberi (in Turkish) |
| Iron preparations (B03A) | B03AE03 | iron and multivitamins | 1 | 1 | syrup | İlaç Rehberi (in Turkish) |
| Iron preparations (B03A) | B03AE10 | various combinations | 5 | 5 | syrup; capsule | İlaç Rehberi (in Turkish) |
| Vitamin B12 and folic acid (B03B) | B03BA01 | cyanocobalamin | 5 | 5 | solution for injection | İlaç Rehberi (in Turkish) |
| Vitamin B12 and folic acid (B03B) | B03BA51 | cyanocobalamin, combinations | 2 | 1 | solution for injection; tablet | İlaç Rehberi (in Turkish) |
| Vitamin B12 and folic acid (B03B) | B03BA53 | hydroxocobalamin, combinations | 2 | 2 | solution for injection | İlaç Rehberi (in Turkish) |
| Vitamin B12 and folic acid (B03B) | B03BB01 | folic acid | 7 | 7 | tablet | İlaç Rehberi (in Turkish) |
Dates of the source lists: TİTCK (Turkish Medicines and Medical Devices Agency) licensed products October 16, 2026, SKRS October 27, 2026, SGK Annex 4/A October 2, 2026 (list of changes October 28, 2026). The counts show the position on that date.
Single-ingredient products by form and strength
Of the 240 products, 158 have one active ingredient and their own ATC code; the table counts them by form and strength. For 148 products the strength was read from the registered name; the 10 products whose name carries no strength are in the “not in name” rows. Combination products are not in this table.
The strength is the figure in the product name; nothing was calculated or converted. This table counts products on the market and is not a dose recommendation. Counted on November 12, 2026.
| ATC code | ATC name | Form | Strength (as in the name) | Products | On SGK list |
|---|---|---|---|---|---|
| A11CA01 | retinol (vit a) | capsule | 30 mg | 1 | 1 |
| A11CC04 | calcitriol | solution for injection | 1 mcg/ml | 4 | 4 |
| A11CC04 | calcitriol | solution for injection | 2 mcg/ml | 4 | 4 |
| A11CC04 | calcitriol | capsule | 0.25 mcg | 1 | 1 |
| A11CC04 | calcitriol | capsule | 0.5 mcg | 1 | 1 |
| A11CC04 | calcitriol | not in record | 1 mcg/ml | 1 | 1 |
| A11CC04 | calcitriol | not in record | 2 mcg/ml | 1 | 1 |
| A11CC05 | colecalciferol | ampoule | 300,000 IU/ml | 1 | 1 |
| A11CC05 | colecalciferol | drops | 15,000 IU/ml | 1 | 1 |
| A11CC05 | colecalciferol | drops | 25,000 IU/ml | 1 | 1 |
| A11CC05 | colecalciferol | drops | 50,000 IU/15 ml | 7 | 7 |
| A11CC05 | colecalciferol | drops | 150,000 IU/10 ml | 10 | 10 |
| A11CC05 | colecalciferol | drops | 200,000 IU/10 ml | 2 | 2 |
| A11CC05 | colecalciferol | film-coated tablet | 2,000 IU | 3 | 3 |
| A11CC05 | colecalciferol | capsule | 1,000 IU | 2 | 1 |
| A11CC05 | colecalciferol | capsule | 2,000 IU | 2 | 2 |
| A11CC05 | colecalciferol | capsule | 4,000 IU | 1 | 1 |
| A11CC05 | colecalciferol | capsule | 5,000 IU | 4 | 4 |
| A11CC05 | colecalciferol | capsule | 10,000 IU | 3 | 3 |
| A11CC05 | colecalciferol | capsule | 20,000 IU | 8 | 8 |
| A11CC05 | colecalciferol | capsule | 50,000 IU | 4 | 4 |
| A11CC05 | colecalciferol | oral solution | 50,000 IU/15 ml | 1 | 1 |
| A11CC05 | colecalciferol | oral solution | 50,000 IU/5 ml | 1 | 1 |
| A11CC05 | colecalciferol | solution | 300,000 IU/ml | 1 | 1 |
| A11CC05 | colecalciferol | not in record | 150,000 IU/10 ml | 1 | 1 |
| A11DA02 | sulbutiamine | coated tablet (dragée) | 200 mg | 1 | 0 |
| A11DA03 | benfotiamine | film-coated tablet | 150 mg | 1 | 0 |
| A11DA03 | benfotiamine | film-coated tablet | 300 mg | 1 | 0 |
| A11GA01 | ascorbic acid (vit c) | effervescent tablet | 1,000 mg | 1 | 0 |
| A11GA01 | ascorbic acid (vit c) | solution for injection | 500 mg/5 ml | 3 | 3 |
| A11HA02 | pyridoxine (vit B6) | tablet | 50 mg | 1 | 1 |
| A11HA03 | tocopherol (vit E) | solution for injection | 300 mg/2 ml | 2 | 2 |
| A11HA03 | tocopherol (vit E) | capsule | 100 IU | 1 | 0 |
| A11HA03 | tocopherol (vit E) | capsule | 200 IU | 1 | 0 |
| A11HA03 | tocopherol (vit E) | capsule | 400 IU | 1 | 0 |
| A11HA03 | tocopherol (vit E) | not in record | 300 mg | 1 | 1 |
| A11HA03 | tocopherol (vit E) | not in record | not in name | 1 | 1 |
| A11HA05 | biotin | tablet | 5 mg | 3 | 3 |
| A11HA30 | dexpanthenol | solution for injection | 500 mg/2 ml | 2 | 2 |
| A11HA30 | dexpanthenol | not in record | 100 mg | 1 | 0 |
| A12AA04 | calcium carbonate | effervescent tablet | 1,000 mg | 1 | 1 |
| A12AA04 | calcium carbonate | film-coated tablet | 500 mg | 1 | 1 |
| A12AA20 | combinations of electrolytes | solution for injection | not in name | 1 | 1 |
| A12BA02 | potassium citrate | prolonged-release tablet | 1,080 mg | 1 | 1 |
| A12CB01 | zinc sulfate | capsule | 50 mg | 3 | 3 |
| A12CB01 | zinc sulfate | capsule | not in name | 1 | 1 |
| A12CB01 | zinc sulfate | syrup | 15 mg/5 ml | 7 | 7 |
| A12CB01 | zinc sulfate | syrup | 25 mg/5 ml | 3 | 3 |
| A12CB01 | zinc sulfate | syrup | 30 mg | 1 | 1 |
| A12CB01 | zinc sulfate | syrup | 30 mg/5 ml | 5 | 5 |
| A12CB01 | zinc sulfate | syrup | not in name | 2 | 2 |
| A12CC02 | magnesium sulfate | ampoule | not in name | 1 | 1 |
| A12CC02 | magnesium sulfate | solution for injection | 1,500 mg/10 ml | 2 | 2 |
| A12CC02 | magnesium sulfate | solution for injection | not in name | 1 | 1 |
| A12CC02 | magnesium sulfate | solution for infusion | 4 g/100 ml | 1 | 1 |
| A12CC02 | magnesium sulfate | solution for infusion | 40 g/1000 ml | 1 | 1 |
| A12CC10 | magnesium oxide | effervescent tablet | 365 mg | 2 | 2 |
| A12CC10 | magnesium oxide | film-coated tablet | 365 mg | 1 | 1 |
| A12CC10 | magnesium oxide | tablet | 365 mg | 2 | 2 |
| B03AA01 | ferrous glycine sulfate | capsule | 100 mg | 2 | 2 |
| B03AA02 | ferrous fumarate | capsule | 100 mg | 1 | 1 |
| B03AA07 | ferrous sulfate | prolonged-release tablet | 80 mg | 1 | 1 |
| B03AB05 | ferric oxide polymaltose complexes | drops | 50 mg/ml | 2 | 2 |
| B03AB05 | ferric oxide polymaltose complexes | oral solution | 100 mg/5 ml | 4 | 4 |
| B03AB05 | ferric oxide polymaltose complexes | sachet | 40 mg | 1 | 1 |
| B03AB05 | ferric oxide polymaltose complexes | sachet | 100 mg | 1 | 1 |
| B03AB05 | ferric oxide polymaltose complexes | syrup | 50 mg/5 ml | 3 | 2 |
| B03AB05 | ferric oxide polymaltose complexes | not in record | 40 mg/5 ml | 1 | 1 |
| B03AB05 | ferric oxide polymaltose complexes | not in record | 50 mg/ml | 1 | 1 |
| B03AB05 | ferric oxide polymaltose complexes | not in record | 100 mg/5 ml | 1 | 1 |
| B03AB09 | ferric proteinsuccinylate | oral solution | 40 mg/15 ml | 1 | 1 |
| B03AD04 | ferric oxide polymaltose complexes | film-coated tablet | not in name | 1 | 1 |
| B03AE10 | various combinations | capsule | not in name | 1 | 1 |
| B03AE10 | various combinations | syrup | not in name | 1 | 1 |
| B03BA01 | cyanocobalamin | solution for injection | 1,000 mcg | 1 | 1 |
| B03BA01 | cyanocobalamin | solution for injection | 1,000 mcg/ml | 3 | 3 |
| B03BA01 | cyanocobalamin | not in record | 1,000 mcg/ml | 1 | 1 |
| B03BB01 | folic acid | tablet | 5 mg | 6 | 6 |
| B03BB01 | folic acid | not in record | 5 mg | 1 | 1 |
How this data was prepared
- Each value is taken from the official source next to it: EFSA, the US National Institutes of Health (NIH), WHO, TEMD (Society of Endocrinology and Metabolism of Türkiye), TİTCK, NICE and approved medicine product information (FDA DailyMed).
- It is the same data that the free tools of the guide use. When the tool data changes, the files are rebuilt and the version number goes up.
- Licensed product counts come from the Doktorclub drug guide, which uses the TİTCK, SKRS and SGK lists. Counts are totals by ATC code.
- It contains no brand, price or treatment dose.
- Separate values exist for children, pregnancy and breastfeeding; this version holds adult values only.